GOHO Share Price | Golden House Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.31%

Poor long term growth as Net Sales has grown by an annual rate of -2.90% and Operating profit at -19.14% over the last 5 years
The company is Net-Debt Free

With ROE of -0.31%, it has a Very Expensive valuation with a 0.61 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

ILS 167 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.15

Return on Equity

-0.31%

Price to Book

0.61

Revenue and Profits:

Net Sales:

13 Million

(Quarterly Results - Mar 2026)

Net Profit:

2 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

2.7%

6 Months

0.85%

1 Year

-19.32%

2 Years

-41.61%

3 Years

-14.04%

4 Years

-19.5%

5 Years

-26.2%

Golden House Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-2.90%

EBIT Growth (5y)

-19.14%

EBIT to Interest (avg)

0.77

Debt to EBITDA (avg)

4.78

Net Debt to Equity (avg)

-0.85

Sales to Capital Employed (avg)

0.11

Tax Ratio

15.27%

Dividend Payout Ratio

2,716.64%

Pledged Shares

Institutional Holding

ROCE (avg)

4.31%

ROE (avg)

3.34%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.61

EV to EBIT

17.22

EV to EBITDA

15.33

EV to Capital Employed

0.54

EV to Sales

2.47

PEG Ratio

Dividend Yield

ROCE (Latest)

3.15%

ROE (Latest)

-0.31%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -5.67% vs 13.71% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -86.36% vs 273.68% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13.30",
          "val2": "14.10",
          "chgp": "-5.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.30",
          "val2": "3.70",
          "chgp": "-10.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "0.80",
          "chgp": "12.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "8.50",
          "chgp": "-103.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.80",
          "val2": "13.20",
          "chgp": "-86.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "227.80%",
          "val2": "245.00%",
          "chgp": "-1.72%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 22.86% vs -34.86% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 75.61% vs -74.53% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "48.90",
          "val2": "39.80",
          "chgp": "22.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.30",
          "val2": "3.80",
          "chgp": "92.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.40",
          "val2": "6.90",
          "chgp": "-50.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.50",
          "val2": "2.20",
          "chgp": "240.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.20",
          "val2": "4.10",
          "chgp": "75.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "132.30%",
          "val2": "71.40%",
          "chgp": "6.09%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]